What are the classifications of traumatic brain injury (TBI) based on Glasgow Coma Scale, duration of loss of consciousness, post‑traumatic amnesia, and imaging findings?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

TBI Classification

Traumatic brain injury is classified primarily by Glasgow Coma Scale (GCS) score into three severity categories: mild (GCS 13-15), moderate (GCS 9-12), and severe (GCS 3-8), supplemented by duration of loss of consciousness, post-traumatic amnesia, and imaging findings.

Primary Classification System: Glasgow Coma Scale

The GCS remains the foundational tool for TBI severity stratification 1, 2:

  • Mild TBI: GCS 13-15
  • Moderate TBI: GCS 9-12
  • Severe TBI: GCS 3-8

Critical Caveat About GCS 13

Patients with GCS 13 warrant special consideration. Despite falling within the "mild" range, they demonstrate significantly higher rates of intracranial lesions requiring neurosurgical intervention and perform on neuropsychological testing similar to moderate TBI patients 1, 2. Some experts advocate reclassifying GCS 13 as moderate TBI to better reflect clinical risk.

Supplementary Classification Criteria

For Mild TBI Diagnosis

According to the American Congress of Rehabilitation Medicine, at least one of the following must be present 1, 2:

  1. Loss of consciousness: <30 minutes duration with GCS 13-15 after the LOC period
  2. Post-traumatic amnesia: <24 hours duration
  3. Altered mental state at time of injury (feeling dazed, disoriented, or confused)

The CDC definition adds 2:

  • Transient confusion, disorientation, or impaired consciousness
  • Memory dysfunction around the time of injury
  • Observable neurologic or neuropsychological dysfunction

Imaging-Based Classification

CT findings provide critical prognostic information independent of GCS 1, 3:

  • Up to 15% of patients with GCS 15 have acute lesions on head CT
  • <1% require neurosurgical intervention
  • Patients with intraparenchymal lesions but GCS 13-15 perform neuropsychologically similar to moderate TBI patients 2

When to Image

Three validated clinical decision rules identify high-risk mild TBI patients requiring CT 3:

  • New Orleans Criteria (GCS 15 only)
  • Canadian CT Head Rule (GCS 13-15)
  • NEXUS-II (GCS 14-15)

Important Limitations and Pitfalls

Single GCS Score Limitations

A single GCS determination is insufficient for diagnosis or prognosis 1, 2, 1. In the original GCS validation studies, approximately 13% of patients who became comatose had an initial GCS of 15 1, 2. The GCS was designed for serial assessments of comatose patients (coma ≥6 hours), not for mild or moderate TBI diagnosis 2.

Serial GCS Scores Are Essential

Serial GCS measurements are the most valuable application in mild TBI 2:

  • A declining GCS predicts worse outcomes
  • An improving GCS predicts better outcomes
  • Serial scores are the best method for detecting patients requiring neurosurgical intervention when CT is unavailable

Sedation Confounds GCS

Sedation can artificially lower GCS scores, making drug-free assessments essential for accurate classification 4.

Prognostic Factors Beyond Classification

Several factors predict worse outcomes independent of GCS 5, 6:

Injury-related:

  • Subdural hemorrhage ≥10 mm (8× increased risk of progression)
  • Epidural hemorrhage ≥10 mm (5× increased risk)
  • Base deficit ≥4 (3× increased risk of progression, 21× increased risk of neurosurgical intervention)
  • Displaced skull fracture (10× increased risk of neurosurgical intervention)
  • History of prior concussions

Patient-related:

  • Age (older patients fare worse)
  • Psychiatric history
  • Lower educational attainment

Clinical:

  • Pupillary reactivity abnormalities
  • Focal neurologic deficits

Emerging Classification Framework

The 2024 NINDS Clinical-Biomarkers-Imaging-Modifiers (CBI-M) framework represents an evolving multidimensional approach that integrates biomarkers (GFAP, UCH-L1, S100B), standardized imaging terminology, and contextual modifiers 7, 8. However, this remains investigational and is not yet validated for routine clinical use.

Practical Application

For acute management, use this algorithmic approach:

  1. Obtain GCS score (preferably serial measurements)
  2. Assess pupillary reactivity to light
  3. Document LOC duration and PTA duration
  4. Apply clinical decision rules to determine CT indication
  5. Consider GCS 13 as higher risk despite "mild" classification
  6. Obtain CT for any GCS ≤14, declining GCS, or positive clinical decision rule criteria
  7. Monitor with serial GCS when CT unavailable or initially negative

Remember: 5-15% of mild TBI patients have compromised function at 1 year 2, so classification severity does not equate to clinical insignificance.

References

Related Questions

How should a 19-year-old male with a mild traumatic brain injury from a left parietal impact 3.5 days ago, persistent headache, minimal scalp bruising, and no red‑flag signs be managed?
What is the severity classification of traumatic brain injury (TBI) for a patient with a Glasgow Coma Scale (GCS) score of 7?
What is the prognosis for a patient with a severe head injury, skull fracture, decorticate posturing, anisocoria, and a Glasgow Coma Scale (GCS) score of 5?
What is the appropriate evaluation and management for chronic memory loss, mood swings, and headaches following traumatic brain injury?
What is the immediate management for a patient with a Glasgow Coma Scale (GCS) score of 11, indicating impaired consciousness, likely due to traumatic brain injury?
What is the recommended lamotrigine (Lamictal) dosing and titration schedule for an adult without hepatic impairment, both with and without concomitant valproate, and what safety monitoring is required?
In a 52-year-old intubated patient with intracerebral hemorrhage and a Glasgow Coma Scale of Eye 1, Verbal (intubated) and Motor 2, what does the presence of fixed, widely dilated pupils indicate?
For a patient with non‑Hodgkin lymphoma status post curative‑intent chemotherapy, what is the recommended imaging surveillance protocol?
For a patient on a stable Suboxone (buprenorphine/naloxone) dose of 8–16 mg daily who requires ADHD treatment, can Adderall (mixed amphetamine salts) be used, and what dosing and monitoring guidelines should be followed?
In which cases should NPH insulin be administered three times daily for a patient with HbA1c ≥11% who is already on NPH but still has elevated fasting, pre‑lunch, and pre‑dinner glucose levels and no contraindications to multiple daily injections?
What is the recommended eradication regimen for Pseudomonas aeruginosa in a patient with bronchiectasis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.